Some studies reported promising results in APC mutated CRC cell lines [15, 16], whilst others showed that nuclear β-catenin bound to LEF-1/TCF transcription factors would be protected from degradation such that TNKSi treatment would not be effective [6]. The gene discussed is APC; the disease is colorectal carcinoma.